IP Library Granted Patent US 9,044,538
Granted Patent B2
US 9,044,538 · App. 12/811,104 · Granted Jun 2, 2015

Automatic injector ram homing

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,044,538
App. No.
12/811,104
Granted
Jun 2, 2015
Kind
B2
Abstract

A power injector ( 40 ) includes a movable ram ( 74 ) operable to interface with and move a plunger ( 90 a/b ) of a syringe ( 86 a/b ). The power injector ( 40 ) may be operable to automatically determine a proper home position for a particular type of the syringe ( 86 a/b ) to be used in a fluid injection sequence. The power injector ( 40 ) may also include a ram homing logic ( 182 ) operable to automatically move the ram ( 74 ) to the home position after the injection sequence. Such automatic homing of the ram ( 74 ) may, for example, be initiated by an end of the injection sequence in preparation for another injection sequence, by opening of a faceplate ( 102 a/b ), by a user input, or by any combination thereof.

Claims (20)

1. A power injector comprising:

a ram;

a syringe type identification logic;

a memory unit, wherein said memory unit comprises a lookup table correlating each one of a plurality of syringe types to one of a plurality of home positions stored in said memory unit, wherein each one of said plurality of syringe types in said lookup table is associated with a particular one of said plurality of home positions in said lookup table, wherein said memory unit comprises a first syringe type and a corresponding first home position, wherein said memory unit comprises a second syringe type and a corresponding second home position, wherein said first and second syringe types are different, and wherein said first and second home positions are different;

a syringe latch;

a syringe latch sensor configured to identify when said syringe latch is in an open position, wherein a syringe may be installed on and removed from said power injector when said syringe latch is in said open position; and

a ram homing logic in communication with said syringe latch sensor and operable to automatically drive said ram to one of said plurality of home positions corresponding to one of said plurality of syringe types: a) based upon occurrence of at least one predetermined condition, wherein said at least one predetermined condition comprises said syringe latch sensor identifying that said syringe latch has been disposed in said open position; b) said syringe latch sensor sending a communication to said ram homing logic after said syringe latch sensor identifies that said syringe latch has been disposed in said open position; and c) based upon an output of said syringe type identification logic, which identifies a syringe type of the syringe that has been installed on said power injector using said syringe latch, and which is used to retrieve a corresponding home position from said memory unit.

2. The power injector of claim 1 , further comprising the syringe, wherein said at least one predetermined condition further comprises another predetermined condition that is selected from the group consisting of activation of a home button on said power injector, a completion of an injection sequence, and fluidly disconnecting a patient from said power injector.

3. The power injector of claim 1 , further comprising a syringe sensor.

4. The power injector of claim 3 , wherein said syringe sensor is selected from the group consisting of an optical sensor and a radio frequency identification (RFID) reader.

5. The power injector of claim 1 , further comprising a ram position encoder.

6. The power injector of claim 1 , wherein said syringe latch comprises a faceplate, and wherein said faceplate comprises a syringe mounting member.

7. The power injector of claim 6 , wherein said faceplate is configured for said first syringe type, wherein a faceplate type of said faceplate that corresponds to said first syringe type is communicated to said power injector by said syringe type identification logic.

8. The power injector of claim 1 , further comprising:

a faceplate mounting member; and

a faceplate, wherein said faceplate comprises a syringe mounting member, wherein said syringe type identification logic is operable to determine a faceplate type of said faceplate when said faceplate is interconnected to said faceplate mounting member, and wherein said syringe latch comprises said faceplate.

9. The power injector of claim 8 , further comprising a faceplate sensor.

10. The power injector of claim 9 , wherein said faceplate sensor is operable to sense a presence of said faceplate installed on said power injector.

11. The power injector of claim 9 , wherein said faceplate sensor is operable to sense said faceplate type of said faceplate installed on said power injector.

12. The power injector of claim 9 , wherein said faceplate sensor is operable to distinguish said faceplate type based on sensing at least one magnet of said faceplate.

Assignments (6)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 037172/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2014
From: MALLINCKRODT LLC
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 034715/0531 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →
CHANGE OF LEGAL ENTITY Recorded Aug 16, 2011
From: MALLINCKRODT INC.
To: MALLINCKRODT LLC
Reel/Frame 026754/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2010
From: PERKINS, JEFFREY A.; MCLEAN, MIKE W.; POTTER, VICTOR L.; FAGO, FRANK M.
To: MALLINCKRODT INC.
Reel/Frame 024606/0879 →